M P Rivey Selected Research

Angiotensin Receptors (Angiotensin II Receptor)

2/2001

Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M P Rivey Research Topics

Disease

1	Heart Failure 02/2001
1	Pain (Aches) 01/2001
1	Thrombophlebitis 01/2001
1	Urinary Tract Infections (Urinary Tract Infection) 01/2001
1	Bacteremia 01/2001
1	Inflammation (Inflammations) 01/2001
1	Injection Site Reaction 01/2001
1	Healthcare-Associated Pneumonia 01/2001
1	Edema (Dropsy) 01/2001
1	Infections 01/2001

Drug/Important Bio-Agent (IBA)

1	Angiotensin Receptors (Angiotensin II Receptor)IBA 02/2001
1	Pharmaceutical PreparationsIBA 02/2001
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2001
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2001
1	Losartan (Cozaar)FDA LinkGeneric 02/2001
1	Angiotensin Receptor AntagonistsIBA 02/2001
1	Vancomycin FDA LinkGeneric 01/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2001
1	Cefazolin (Ancef)FDA LinkGeneric 01/2001
1	quinupristin-dalfopristin (Synercid)FDA Link 01/2001
1	Oxacillin (Prostaphlin)FDA LinkGeneric 01/2001

Therapy/Procedure

1	Therapeutics 02/2001
1	Combined Modality Therapy 02/2001